Microembolism during foam sclerotherapy of varicose veins.

Polidocanol for endovenous microfoam sclerosant therapy. Expert Opin Investig Drugs (2009) 1.12

More on microembolism and foam sclerotherapy. N Engl J Med (2008) 0.96

Polidocanol versus hypertonic glucose for sclerotherapy treatment of reticular veins of the lower limbs: study protocol for a randomized controlled trial. Trials (2014) 0.81

Trends in varicose vein therapy in England: radical changes in the last decade. Ann R Coll Surg Engl (2010) 0.80

Benefits of polidocanol endovenous microfoam (Varithena®) compared with physician-compounded foams. Phlebology (2015) 0.80

Paradoxical embolism following intralesional sclerotherapy for cervical venous malformation. BMJ Case Rep (2014) 0.79

Balloon-occluded Retrograde Transvenous Obliteration (BRTO): Technique and Intraprocedural Imaging. Semin Intervent Radiol (2011) 0.76

An unusual cause of pulmonary artery pseudoaneurysm: acrylate embolism. Interact Cardiovasc Thorac Surg (2012) 0.76

Efficacy and Safety of Balloon-Occluded Retrograde Transvenous Obliteration with Sodium Tetradecyl Sulfate Liquid Sclerotherapy. Korean J Radiol (2016) 0.75

Polidocanol versus glucose in the treatment of telangiectasia of the lower limbs (PG3T): Protocol for a randomized, controlled clinical trial. Medicine (Baltimore) (2016) 0.75

Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial. Lancet Oncol (2013) 4.75

Induced Brugada-type electrocardiogram, a sign for imminent malignant arrhythmias. Circulation (2008) 1.81

Absence of reverse electrical remodeling during regression of volume overload hypertrophy in canine ventricles. Cardiovasc Res (2003) 1.45

Adenosine testing after second-generation balloon devices (cryothermal and laser) mediated pulmonary vein ablation for atrial fibrillation. J Interv Card Electrophysiol (2014) 1.29

Intra-ventricular resynchronization for optimal left ventricular function during pacing in experimental left bundle branch block. J Am Coll Cardiol (2003) 1.08

Basal cell carcinoma and trichoepithelioma: a possible matter of confusion. Int J Dermatol (2008) 1.06

Comparison of a non-invasive arterial pulse contour technique and echo Doppler aorta velocity-time integral on stroke volume changes in optimization of cardiac resynchronization therapy. Europace (2010) 1.02

Quantification of interventricular asynchrony during LBBB and ventricular pacing. Am J Physiol Heart Circ Physiol (2002) 0.98

Treatment of lymphangioma circumscriptum with the intense pulsed light system. Int J Dermatol (2007) 0.97

Pacing-induced dys-synchrony preconditions rabbit myocardium against ischemia/reperfusion injury. Circulation (2006) 0.92

Bullous congenital ichthyosiform erythroderma of Brocq. Int J Dermatol (2007) 0.92

Beneficial effects of biventricular pacing in chronically right ventricular paced patients with mild cardiomyopathy. Europace (2009) 0.91

Outcomes and side effects of duplex-guided sclerotherapy in the treatment of great saphenous veins with 1% versus 3% polidocanol foam: results of a randomized controlled trial with 1-year follow-up. Dermatol Surg (2007) 0.91

Superparamagnetic iron oxide nanoparticles as radiosensitizer via enhanced reactive oxygen species formation. Biochem Biophys Res Commun (2012) 0.90

Cardiac resynchronization therapy: state-of-the-art of current applications, guidelines, ongoing trials, and areas of controversy. Circulation (2013) 0.90

Mechano-energetics of the asynchronous and resynchronized heart. Heart Fail Rev (2011) 0.83

Tailoring cardiac resynchronization therapy using interventricular asynchrony. Validation of a simple model. Am J Physiol Heart Circ Physiol (2005) 0.82

Animal models of dyssynchrony. J Cardiovasc Transl Res (2011) 0.79

Superparamagnetic iron oxide nanoparticles as novel X-ray enhancer for low-dose radiation therapy. J Phys Chem B (2014) 0.78

Cardiac resynchronization therapy: refocus on the electrical substrate. Circ J (2011) 0.78

Vectorcardiography for optimization of stimulation intervals in cardiac resynchronization therapy. J Cardiovasc Transl Res (2015) 0.78

Vectorcardiography as a tool for easy optimization of cardiac resynchronization therapy in canine left bundle branch block hearts. Circ Arrhythm Electrophysiol (2012) 0.77

Different regions of latest electrical activation during left bundle-branch block and right ventricular pacing in cardiac resynchronization therapy patients determined by coronary venous electro-anatomic mapping. Eur J Heart Fail (2014) 0.76

Clinical heterogeneity in sodium channelopathies. What is the meaning of carrying a genetic mutation? Cardiology (2007) 0.76

T-wave area predicts response to cardiac resynchronization therapy in patients with left bundle branch block. J Cardiovasc Electrophysiol (2014) 0.76

Cardiac memory and cortical memory. Circulation (2004) 0.75

The role of acute invasive haemodynamic measurements in cardiac resynchronization therapy: looping towards prediction of long-term response and therapy optimization. Eur J Heart Fail (2013) 0.75

Destructive basal cell carcinoma in a patient with basal cell nevus syndrome and an interstitial deletion of chromosome 9q22. Dermatol Surg (2009) 0.75

Helmet-induced neck degloving in a motorcyclist. J Trauma (2005) 0.75

[Foam echosclerotherapy for trunk varicositas]. Ned Tijdschr Geneeskd (2009) 0.75

Cardiovascular outcome 6 months after severe coronavirus disease 2019 infection. J Hypertens (2022) 0.75

Superficial thrombophlebitis of the venous dorsal arch of the foot and deep venous thrombosis after foam sclerotherapy. Int J Dermatol (2008) 0.75